| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.24 | 1e-05 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.21 | 3e-05 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.15 | 8e-05 |